The effectiveness of Check of Medication Appropriateness for antimicrobial stewardship: an interrupted time series analysis

Author:

Quintens Charlotte12ORCID,Peetermans Willy E34,Lagrou Katrien35,Declercq Peter12ORCID,Schuermans Annette67,Debaveye Yves89,Van den Bosch Bart610,Spriet Isabel12

Affiliation:

1. Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium

2. Pharmacy Department, University Hospitals Leuven, Leuven, Belgium

3. Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium

4. Department of General Internal Medicine, University Hospitals Leuven, Leuven, Belgium

5. Clinical Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium

6. Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium

7. Department of Infection Control and Epidemiology, University Hospitals Leuven, Leuven, Belgium

8. Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium

9. Department of Intensive Care Medicine, University Hospitals Leuven, Leuven, Belgium

10. Department of Information Technology, University Hospitals Leuven, Leuven, Belgium

Abstract

Abstract Objectives Inappropriate prescribing of antimicrobials in hospitals contributes to the emergence of resistance and adverse drug events. To support antimicrobial stewardship (AMS), clinical decision rules focusing on antimicrobial therapy were implemented in the ‘Check of Medication Appropriateness’ (CMA). The CMA is a hospital-wide pharmacist-led medication review service consisting of a clinical rule-based screening for potentially inappropriate prescriptions (PIPs). We aimed to investigate the impact of the CMA on antimicrobial prescribing. Methods An interrupted time series study was performed at the University Hospitals Leuven. The pre-implementation cohort was exposed to standard-of-care AMS. Afterwards, an AMS-focused CMA comprising 41 specific clinical rules, targeting six AMS objectives, was implemented in the post-implementation period. A regression model was used to assess the impact of the intervention on the number of AMS-related residual PIPs between both periods. The total number of recommendations and acceptance rate was recorded for the 2 year post-implementation period. Results Pre-implementation, a median proportion of 75% (range: 33%–100%) residual PIPs per day was observed. After the CMA intervention, the proportion was reduced to 8% (range: 0%–33%) per day. Use of clinical rules resulted in an immediate relative reduction of 86.70% (P < 0.0001) in AMS-related residual PIPs. No significant underlying time trends were observed during the study period. Post-implementation, 2790 recommendations were provided of which 81.32% were accepted. Conclusions We proved that the CMA approach reduced the number of AMS-related residual PIPs in a highly significant and sustained manner, with the potential to further expand the service to other AMS objectives.

Funder

Clinical Research Fund of the University Hospitals Leuven

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3